The US Treasury has announced new efforts to curb international tax avoidance measures known as corporate inversions.
The new rules have cast doubt on a proposed $160 billion deal between pharmaceutical companies Pfizer and Allergan.
From Washington, Daniel Ryntjes reports...
IN: The new package...
OUT: SOC
DUR: 35"